CaliPharms Inc (KGET)

[Afterwork]

CaliPharms Enters Discussions With Beverage Master DistributorPress Release | 07/25/2018
CaliPharms, Inc. (OTCPink: KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" has entered discussions with a Beverage Master Distributor.



Management has concluded extensive research on the CBD beverage market and determined it is an excellent market for CaliPharms to enter at this time in the USA. CaliPharms has entered discussions to acquire the master distributorship with the intention of developing its own CBD Beverage line and using the distribution channels to place future products.



Cannabidiol (CBD) is a natural compound found in cannabis and is known for its medicinal benefits. It is the compound of cannabis minus the THC or illusionary compound. CBD is now legal in most states of the USA, Canada and 22 countries in Europe with increasing pressures on Governments to completely legalize its use;



In the US CBD market is estimated to grow to $2.1B by 2020* (Investing News, 2017), whilst the International market for cannabis is projected to hit $31.4 billion by 2021 (Zhang, M 2017)